Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 02, 2014
Technology Networks
Register | Sign in
Home Page>News

  News Archive

Lightlake Signs Agreement with Commercial Contract Manufacturer
Thursday, July 10, 2014
Agreement to commence production of naloxone-based opioid overdose reversal treatment.

Portola Enters into Clinical Collaboration Agreement with Daiichi Sankyo
Thursday, July 10, 2014
Phase 3 collaboration agreements in place with all direct Factor Xa inhibitor manufacturers while Portola retains all rights to andexanet alfa.

Resverlogix Secures an Additional $30 Million from Citibank Loan
Saturday, July 05, 2014
Special meeting of shareholders called to approve.

RXi Pharmaceuticals Celebrates Expansion of its Operations in Massachusetts
Saturday, July 05, 2014
Official opening of Company’s new office and laboratory in the Marlborough Technology Center.

Researchers Demonstrate Promise of Dicerna Investigational Therapy in Preclinical Model of PH1
Friday, July 04, 2014
DCR-PH1 uses proprietary dicer substrate RNAi technology to inhibit enzyme implicated in rare liver disorder.

4SC Hires Experienced Pharmaceutical Manager and Oncology Expert
Friday, July 04, 2014
Dr Erich Enghofer joins 4SC in the newly created position of Executive Vice President.

Recipharm and Pharmanest Form Collaboration
Friday, July 04, 2014
New pharmaceutical manufacturing contract for commercial manufacture and supply of SHACT.

PAREXEL Announces Acquisition of ATLAS Medical Services
Thursday, July 03, 2014
Acquisition strengthens PAREXEL’s presence in Turkey, the Middle East and North Africa.

Isis Pharmaceuticals Earns $1 Million from GSK
Thursday, July 03, 2014
Advances HBV development program to develop antisense drugs.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 3115
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to